Structural modifications of berberine and their binding effects towards polymorphic deoxyribonucleic acid structures:...

Area of Science:

• Medicinal Chemistry
• Molecular Biology
• Pharmacology

Background:

• Berberine (BBR), a plant-derived alkaloid, has traditional medicinal uses and broad pharmacological effects.
• BBR exhibits anti-tumor properties by interacting with DNA, including B-DNA and its polymorphs, which are implicated in genetic instability and cancer.
• Limitations of BBR include poor lipophilicity and rapid metabolism, hindering clinical application.

Purpose of the Study:

• To review advancements in Berberine derivatives for binding to polymorphic DNA structures over the past 20 years.
• To discuss strategies for structural modification of BBR to enhance DNA binding and bioavailability.
• To analyze the structure-activity relationships (SAR) of BBR derivatives concerning DNA binding.

Main Methods:

• Literature review of studies on Berberine derivatives and their interaction with DNA.
• Analysis of structural modifications aimed at improving BBR's DNA binding affinity and pharmacokinetic properties.
• Examination of structure-activity relationship (SAR) data for BBR derivatives targeting polymorphic DNA structures.

Main Results:

• Numerous BBR derivatives have been developed with enhanced binding affinities to various DNA structures.
• Structural modifications have successfully improved BBR's lipophilicity and bioavailability.
• Significant progress has been made in understanding the SAR of BBR derivatives for DNA binding.

Conclusions:

• Structural modification is a viable strategy to overcome BBR's limitations and enhance its anti-tumor efficacy.
• BBR derivatives show promise as therapeutic agents targeting DNA structures in cancer treatment.
• Further research into BBR derivatives and their DNA interactions can lead to novel anti-cancer drugs.